Bonus Episode: Thomas talks with STAT

Thomas Goetz· Host0:00

[instrumental music] This is Drug Story. I'm Thomas Goetz. Today, we're dropping in a bonus episode. This is a conversation that I had recently with Stat, the superb publication about health and medicine. If you are in the business of health and medicine, you probably already know all about Stat. For more than a decade, they have been doing fantastic reporting from the frontiers of biotech and public health and policy. And Stat really has been a key source for Drug Story. I get a lot of pharma news and inside industry reporting there. So I was honored to talk with Stat's Tori Bosche for their first opinion podcast, and I thought that the Drug Story audience would appreciate this conversation. If you're curious what inspired the idea for this show, or have a notion about the bigger ideas behind this show, or you wonder why I think everyone should get a degree in public health, well, you'll get some of that backstory here. And meanwhile, we are indeed still working on season two. When we can, we will pop other bonus episodes in here just like this one, just to remind you that we still exist before our big reveal of season two later this year. Okay. Thank you for listening, and here's my conversation with Stat.

Tori Bosch· Host1:16

Whether it's Ambien or Wegovy, ivermectin or fluoride, every drug in your medicine cabinet or advertised on TV has a story